Speakers

Dame Sally Davies was appointed as the UK Government’s Special Envoy on AMR in 2019. She is also the 40th Master of Trinity College, Cambridge University.  

Dame Sally was the Chief Medical Officer for England and Senior Medical Advisor to the UK Government from 2011-2019. She is a leading figure in global health, having served as a member of the World Health Organisation (WHO) Executive Board 2014-2016, and as co-convener of the United Nations Inter-Agency Co-ordination Group (IACG) on Antimicrobial Resistance (AMR), reporting in 2019. In November 2020, Dame Sally was announced as a member of the new UN Global Leaders Group on AMR, serving alongside Heads of State, Ministers and prominent figures from around the world to advocate for action on AMR. 

In the 2020 New Year Honours, Dame Sally became the second woman (and the first outside the Royal family) to be appointed Dame Grand Cross of the Order of the Bath (GCB) for services to public health and research, having received her DBE in 2009. 

Professor Lord Ara Darzi of Denham is the Executive Chair of the Fleming Initiative – a global movement to combat antimicrobial resistance under the patronage of HRH Prince William the Prince of Wales.

Professor Darzi is also Director of the Institute of Global Health Innovation at Imperial College London and holds the Paul Hamlyn Chair of Surgery. He serves as a Consultant Surgeon at Imperial College NHS Trust and the Royal Marsden NHS Foundation Trust. Professor Darzi also chairs the NHS Accelerated Access Collaborative and is Executive Chair of both the World Innovation Summit for Health and the Pre-emptive Health & Medicine Initiative at Flagship Pioneering.

As a former Minister for Health in the United Kingdom, Professor Darzi has championed healthcare reform and has innovative policy to improve patient outcomes. Most recently, he led both the Independent Review of the NHS and the Future State of Health commissioned by the Secretary of State for Health and Social Care.

Professor Darzi was knighted in 2002 and introduced as Lord Darzi of Denham to the House of Lords in 2007. He was appointed to His Majesty’s Most Honourable Privy Council in 2009 and awarded the prestigious Order of Merit in 2016.

Hon. Julia Gillard AC served as the 27th Prime Minister of Australia (2010-13) and is a longstanding advocate for gender equity through her work with the Global Institute for Women’s Leadership. She is currently Chair of the Wellcome Trust, one of the world’s largest philanthropic organisations funding science to solve urgent health challenges. A passionate supporter of science and international collaboration, Julia brings a unique perspective to the AMR 2026 Summit.

Erin Duffy is the Chief of Research & Development at CARB-X. CARB-X is a global biopharmaceutical accelerator for the discovery and early development of products to prevent, diagnose and treat bacterial infections. Most of her professional growth was with Melinta Therapeutics (founded as Rib-X Pharmaceuticals) where ultimately she became EVP, Chief Scientific Officer and R&D site head.  Her entry into the pharmaceutical sector began with Pfizer Central Research.  Erin’s formal training was in chemistry at Yale University.

Fiona Reynolds is an independent director and advisory board member working globally across the business and investor sectors on sustainability issues.

Fiona Reynolds joined FAIRR in 2024 as President. In this strategic advisory role, Fiona draws on her vast experience to help further increase the initiative’s impact in the broader ecosystem of investors, funders, and partners.

Fiona has been recognised as one of the top 20 influential figures in global sustainability by Barron’s magazine.

Fiona led the Principles for Responsible Investment (PRI) as CEO for almost a decade until early 2022.

She is the Chair of the UN Global Compact Network Australia and serves on the Board of Frontier Advisors, the Australian Sustainable Finance Institute, and the Achieve Foundation. She is on the Advisory Boards of Affirmative Investment Management, and ROC Partners. She chairs the ESG Advisory Board for Qualitas and is on the think tanks Climate Catalyst, and the UBS Sustainability and Impact Forum, as well the Advisory Committee for the NSW Commissioner for Anti-Slavery and the Australian Human Rights Institute.

Professor Mark D.M. Davis is a medical sociologist, School of Social Sciences, Monash University. His research, education and leadership addresses social public health, with a focus on publics and their engagements with bioscience, lived experience-led policy design and the participation of underserved and minoritised groups. His research has been supported with funding from the UK’s ESRC, and the ARC and MRFF in Australia. He leads the Infection, Immunity and Society group at Monash. Mark’s book Selling Immunity: Self, Culture and Economy in Healthcare and Medicine was shortlisted for the 2025 Foundation for the Sociology of Health Illness book prize.

Dr Kylie Hewson has a degree in Biotechnology and a PhD in Molecular Virology. Kylie has worked for over 15 years in the Australian agriculture sector (predominately poultry) as a scientist, research manager and advocate for ensuring quality science is not only produced, but also made accessible and able to be used in setting policy and achieving meaningful impact.

She has received national and international awards for her science and advocacy, and sector awards for science communication. Kylie has represented industry on several high-level cross-sectoral and government committees, with extensive experience as Chair, across issues such as biosecurity, food safety, animal health and antimicrobial stewardship. Kylie brings a variety of perspectives from her lived experiences having worked across the private sector, government, academia, research funding organisations, representative organisations and managing her own company.

Kylie has a particular interest in capacity building and has established and coordinated numerous initiatives for the professional development of scientists, and is always seeking to connect people with opportunities. 

Professor Branwen Morgan PhD has held numerous senior roles that bridge academic institutions, government, publicly listed companies, and not-for-profit organisations. Branwen’s journey from molecular biologist to journalist, consultant, and influential science leader in antimicrobial resistance exemplifies the power and flexibility of a portfolio-based career in the life sciences sector. She is based at CSIRO where she leads the Minimising Antimicrobial Resistance (AMR) Consortium. Together with her team, she has significantly improved the visibility of AMR amongst policymakers, created new industry, research, and government connections, and catalysed millions of dollars of investment into antimicrobial resistance research. The consortium’s work emphasises the interconnections between antimicrobial use and resistance across the human, animal, and environmental sectors, addressing research implementation and policy barriers.

Dr Jomana F. Musmar is a global health policy expert and the Founder and Senior Consultant of Advisors of Global Health, LLC. With decades of experience across leading U.S. agencies—including HHS, DoD, and USDA—she excels in government affairs, policy development, and coalition building. Dr Musmar established and served as the Executive Director of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB), where she coordinated with over 600 experts to drive One Health and antimicrobial resistance initiatives. At HHS, she also served as Deputy Director for Strategic Initiatives, leading national strategies on vaccines, HIV/AIDS, and infectious diseases, and managing interagency operations in emergencies such as COVID-19. She is also a Leadership Council Member at NIAMRRE and an Honorary Senior Lecturer at the University of Bristol. Dr Musmar’s expertise, recognized internationally, has shaped policy and operations at organisations, government agencies, and academic institutions worldwide.

Moana is a Senior ESG and Sustainability Analyst at Alphinity Investment Management who contributes to the integration of environmental, social and governance risks into the investment process. She conducts research and data analysis to monitor ongoing ESG risks, controversies, emerging topics and supports Alphinity’s stewardship activities in the areas of company engagement, collaborative engagement, thematic research and proxy voting.

Moana also has an active role in supporting the universe construction for Alphinity’s two sustainable strategies and completes company and thematic analysis which assists the Sustainable Compliance Committee in their decisions. She leads the annual data assurance process for both sustainable strategies.

Moana joined Alphinity in 2020 and has a Bachelor of Science and a Bachelor of Commerce degrees from the University of Sydney, with majors in Biology, Environmental Studies and Finance.

Professor Paterson directs ADVANCE-ID (ADVANcing Clinical Evidence for Infectious Diseases) at Saw Swee Hock School of Public Health and Yong Loo Lin School of Medicine at National University of Singapore. ADVANCE-ID is a clinical trials network comprising more than 100 hospitals across 20 countries in Asia. This network is jointly funded by the Wellcome Trust and a number of Singaporean institutions with an aim to conduct clinically important trials in the field of antimicrobial resistance (AMR).

This comprises trials of antibiotics, diagnostics and prevention strategies. He is also an Honorary Professor at the University of Queensland and has more than 600 peer-reviewed publications predominantly in the area of AMR. His research focuses on the molecular and clinical epidemiology of infections with antibiotic-resistant organisms, with the intent of translating knowledge into optimal prevention and treatment of these infections. Multi-country clinical trials are the major component of his research portfolio, and the predominant focus of ADVANCE-ID.

Professor Brett Sutton is a Director at CSIRO, Australia’s national science agency, leading the Health & Biosecurity Research Unit, comprising over 350 researchers and support staff in areas of digital health, human health and plant, animal and environmental biosecurity.

A qualified public health physician, he brings extensive experience and clinical expertise in public health and communicable diseases, developed through roles in government, emergency medicine, and international fieldwork.

Before joining CSIRO, Brett served as Victoria’s Chief Health Officer and Chief Human Biosecurity Officer, heading the Health Protection Branch within the Victorian Department of Health.

With specialist knowledge in tropical medicine and infectious diseases, Brett has worked extensively in lower-middle-income countries and complex humanitarian settings, including in Afghanistan, Ethiopia, Kenya, Timor-Leste, and Fiji.

Professor Sutton is a Fellow of the Royal Society for Public Health, a Fellow of the Australasian College of Tropical Medicine, and a Fellow of the Australasian Faculty of Public Health Medicine (AFPHM). He is also a member of the Faculty of Travel Medicine.